Abbvie Inc (ABBV)
204.08 +2.00 (+0.99%) 02/24/25 [NYSE]
203.75 x 2 205.38 x 1
Realtime by (Cboe BZX)
203.75 x 2 205.38 x 1
Realtime 204.00 -0.08 (-0.04%) 19:11 ET
for Mon, Feb 24th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Sales | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
Cost of Goods | 16,904,000 | 20,415,000 | 17,414,000 | 17,446,000 | 15,387,000 |
Gross Profit | 39,430,000 | 33,903,000 | 40,640,000 | 38,751,000 | 30,417,000 |
Operating Expenses | 30,293,000 | 21,146,000 | 22,523,000 | 20,827,000 | 19,054,000 |
Operating Income | 9,137,000 | 12,757,000 | 18,117,000 | 17,924,000 | 11,363,000 |
Interest Expense | 2,160,000 | 1,684,000 | 2,044,000 | 2,384,000 | 2,280,000 |
Other Income | -3,261,000 | -4,823,000 | -2,596,000 | -2,551,000 | -5,685,000 |
Pre-tax Income | 3,716,000 | 6,250,000 | 13,477,000 | 12,989,000 | 3,398,000 |
Income Tax | -570,000 | 1,377,000 | 1,632,000 | 1,440,000 | -1,224,000 |
Net Income Continuous | 4,286,000 | 4,873,000 | 11,845,000 | 11,549,000 | 4,622,000 |
Minority Interests | 8,000 | 10,000 | 9,000 | 7,000 | 6,000 |
Net Income | $4,278,000 | $4,863,000 | $11,836,000 | $11,542,000 | $4,616,000 |
EPS Basic Total Ops | 2.40 | 2.73 | 6.65 | 6.48 | 2.73 |
EPS Basic Continuous Ops | 2.42 | 2.76 | 6.69 | 6.52 | 2.77 |
EPS Diluted Total Ops | 2.39 | 2.72 | 6.63 | 6.45 | 2.72 |
EPS Diluted Continuous Ops | 2.42 | 2.75 | 6.66 | 6.50 | 2.76 |
EPS Diluted Before Non-Recurring Items | 10.12 | 11.11 | 13.77 | 12.70 | 10.56 |
EBITDA(a) | $17,523,000 | $21,455,000 | $26,584,000 | $26,445,000 | $17,834,000 |